Additionally, Δ16HER2 was readily expressed as early as 11 W in EMI KO mammary glands, both at RNA and protein level, aligning with the earlier tumor onset observed in this genetic background (Fig. 4d, e). This evidence concerns the gene EMILIN1 and neoplasm.